A new meta-analysis of data regarding the clinical significance of the reported increased risks of bleeding when using clopidogrel in combination with PPIs was published in Open Heart. Data from patients on clopidogrel with and without PPIs was analysed. A total of 39 studies with 214 851 patients were analysed.
The public will soon be invited to comment on draft MCC regulations for the legal production of cannabis for medicinal use.
A certification body, Tuv Sud, has approved a fertility tracking device to be marketed as a medical device for contraception in the European Economic Area. In conjunction with a thermometer, the app – called Natural Cycles – uses an algorithm to determine on which days unprotected intercourse would not be advisable.
The NEJM (New England Journal of Medicine) are keeping up with the times, and producing short videos. The new research findings on the controversial cardiovascular safety of celecoxib are summarised in this video on their website. It’s less than three minutes long, so grab a cup of tea and check it out here.